February 2, 2018 - It is with a mixture of emotion that we must inform you that Interceder will cease its service over the coming weeks. For nearly a decade we have been helping you find relevant information across thousands of news and social sources, to keep you abreast of the latest news. We’re a small team of two who have run Interceder outside of our regular day jobs and are intensely proud of what we managed to accomplish over the years. Through a lack of time to maintain the site and growing costs associated with acquiring, indexing, analysing and hosting content we will be shutting down Interceder for good. All things reach a natural end, but we could not be more grateful for the way you made us part of your day, so instead of saying goodbye we would just like to say thank you!

Alnylam Pharmaceuticals Inc

Latest articles

Business Standard India
Sanofi SA set to buy US drug maker Bioverativ for more than $11.5 bn: WSJBioverativ at about $105 a share, the Journal reported. Sanofi SA is close to
Business Standard India / Posted 30 days ago
Bioverativ at about $105 a share, the Journal reported. Sanofi SA is close to a deal to take over US drug maker Bioverativ Inc for more than $11.5 billion, the Wall Street Journal reported, citing people familiar with the matter. The price... Read more

In this news